Opening #HEMEPATH Diffuse Large B-Cell Lymphoma: An update
#HEMEPATH Diffuse Large B-Cell Lymphoma: An update
- Length
- 1 h 16 min
- Level
- Undergraduate
- Recorded
- pathCast2024 · Standalone Lecture
Chapter 1 of 11: Before the lecture
Analyzes diffuse large B-cell lymphoma subtypes, genetic double-hits, and molecular signatures.
Diffuse Large B-Cell Lymphoma diagnostics require navigating cell-of-origin classifications, genetic rearrangements, and genomic signatures. L. Jeffrey Medeiros examines diffuse large B-cell lymphoma and high-grade B-cell subtypes, tracing how pathology informs clinical prognostication and treatment. The session evaluates the limitations of the Hans immunohistochemical algorithm against gene expression profiling and examines next-generation sequencing categories like MCD and EZB. Case reviews highlight double-hit lymphomas involving MYC alongside BCL2 or BCL6, revealing discrepancies between standard fluorescence in situ hybridization and modern expression signatures.
Diffuse Large B-Cell Lymphoma diagnostics require navigating cell-of-origin classifications, genetic rearrangements, and genomic signatures. L. Jeffrey Medeiros examines diffuse large B-cell lymphoma and high-grade B-cell subtypes, tracing how pathology informs clinical prognostication and treatment. The session evaluates the limitations of the Hans immunohistochemical algorithm against gene expression profiling and examines next-generation sequencing categories like MCD and EZB. Case reviews highlight double-hit lymphomas involving MYC alongside BCL2 or BCL6, revealing discrepancies between standard fluorescence in situ hybridization and modern expression signatures.
World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias
RICOVER-60 trial
Chinese study on DLBCL clinical presentation
Original International Prognostic Index paper
NCCN-IPI paper
This lecture
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
German study on centroblastic vs immunoblastic variants
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Cell-of-origin classification by immunohistochemistry in R-CHOP treated diffuse large B-cell lymphoma
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Blood 106: 275, 2004
Nat Med 24:679, 2018
Blood 120: 3986, 2021
N Engl J Med 378:1398, 2018
Blood 135:1759, 2020
Cancer Cell 37: 551, 2020
Mod Pathol 36 (Jan): 100007, 2023
Cancer Discovery 11: 1468, 2021
Mod Pathol 19: 25, 2006
Blood 117: 2319, 2011
Blood 121: 4021, 2013
Mod Pathol 32:48, 2019
Nature 403: 503, 2000
Landsburg et al. Cancer 122:559, 2016; Gebauer et al. Leuk Lymphoma 56:179, 2015
J Clin Oncol 37: 190, 2019
Blood 134: 1528, 2019
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab-Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Pathology 50: 74, 2018
Leukemia 37: 422, 2023
A predictive model for aggressive non-Hodgkin lymphoma
A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications
Double hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma